{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "10000907",
    "licUnit": "1",
    "validDate": "2026-07-01 00:00:00.000",
    "issueDate": "2011-07-01 00:00:00.000",
    "oriIssueDate": "2011-07-01",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA01000090700",
    "prodNameC": "安挺樂 靜脈點滴注射劑",
    "prodNameE": "Actemra  Solution for Infusion",
    "indicationsName": [
        "1. 類風濕性關節炎(RA) ：合併methotrexate (MTX)用於治療成年人中度至重度類風濕性關節炎，曾使用一種或一種以上之DMARD藥物治療或腫瘤壞死因子拮抗劑(TNF antagonist)治療而反應不佳或無法耐受的病人。在這些病人中，若病人對MTX無法耐受或不適合繼續投與MTX，可給予本品單獨治療。當與MTX合併使用時，經X光量測，可減緩關節傷害惡化速度，此外，經HAQ-DI量表評估，可改善生理功能。\r\n\r\n2. 類風濕性關節炎(RA) –未曾使用MTX治療的RA： 合併methotrexate (MTX)適用於治療先前未曾使用MTX治療的重度、活動性、進行性類風濕性關節炎成人病人。在這些病人中，若病人對MTX無法耐受或不適合繼續投與MTX，可給予本品單獨治療。當與MTX合併使用時，經X光量測，可減緩關節傷害惡化速度。\r\n\r\n3. 多關節性幼年型原發性關節炎(PJIA)：與methotrexate (MTX)併用，適用於治療2歲以上的活動性多關節性幼年型原發性關節炎，且對MTX治療反應不佳者。對於無法耐受或不適合繼續MTX治療的病人，可單獨使用本品。\r\n\r\n4. 全身性幼年型原發性關節炎(SJIA)：適用於治療2歲以上的活動性全身性幼年型原發性關節炎病人，且對NSAID及類固醇治療反應不佳或無法耐受者。\r\n\r\n5. 細胞激素釋放症候群(CRS)：適用於治療嵌合抗原受體(CAR) T 細胞誘發之重度或危及生命細胞激素釋放症候群的成人及2 歲以上兒童病人。\r\n\r\n6. 新型冠狀病毒疾病(COVID-19，嚴重特殊傳染性肺炎)：適用於治療正在接受全身性皮質類固醇治療且須補充氧氣、使用非侵入性或侵入性機械呼吸器、或使用體外膜氧合器(葉克膜\/ECMO)之住院成年病人的新型冠狀病毒疾病(COVID-19，嚴重特殊傳染性肺炎)。"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "20毫升",
            "packageUnit": "13"
        },
        {
            "packageSpec": "10毫升",
            "packageUnit": "13"
        },
        {
            "packageSpec": "4毫升",
            "packageUnit": "13"
        },
        {
            "packageSpec": "100瓶以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": null,
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "06A9E912-BE44-4084-B094-E4C86B58FFE0",
    "subCategory": [],
    "ingredientsDesc": [
        "Tocilizumab"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "67 成品已完成元素不純物評估(Option 1、2a、2b)"
    ],
    "applicantName": "台灣中外製藥股份有限公司",
    "applicantAddr": "台北市松山區敦化北路260號3樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "A31B688D-CD6F-4C85-95DC-471237975568",
            "factoryCode": "1",
            "factoryName": "UTSUNOMIYA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.",
            "factoryAddr": "16-3 KIYOHARA KOGYODANCHI, UTSUNOMIYA-CITY, TOCHIGI, JAPAN",
            "factoryCompanyAddr": null,
            "countryCode": "JP",
            "processCode": [
                {
                    "value": "66",
                    "name": "成品製造廠"
                }
            ],
            "processCodeStr": "66;成品製造廠",
            "factoryKind": "M",
            "factoryNo": "FJP0724000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "2A43FE1C-3445-4B81-A1E4-8988BF7A4BF5",
            "factoryCode": "2",
            "factoryName": "Nipro Pharma Corporation Ise Plant",
            "factoryAddr": "647-240, Ureshinotengeji-cho, Matsusaka-shi, Mie 515-2302, Japan",
            "factoryCompanyAddr": "",
            "countryCode": "JP",
            "processCode": [
                {
                    "value": "1A",
                    "name": "二級包裝廠"
                }
            ],
            "processCodeStr": "1A;二級包裝廠",
            "factoryKind": "M",
            "factoryNo": "FJP9444000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "FF7B689D-8E89-4592-B0FE-709BA1A03ADF",
            "factoryCode": "2",
            "factoryName": "Samsung Biologics Co. Ltd.",
            "factoryAddr": "300 Songdo bio-daero, Yeonsu-gu, Incheon City, Korea 21987, Korea Republic",
            "factoryCompanyAddr": "",
            "countryCode": "KR",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FKR0186000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013002800",
            "ingredientsName": "Tocilizumab",
            "ingredientsDesc": "Tocilizumab",
            "concentDesc": null,
            "concent": "20.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L04AC07"
        }
    ],
    "licBaseId": "D262BFF7-1B49-455C-B0B4-E6EC6F0BB3D1"
}